In order to explore whether the constructed model can distinguish OC from benign ovarian disease, anti-TAA autoantibodies (anti-CFL1, anti-EZR, and anti-CYPA) were detected in the BD validation cohort. The gene discussed is CFL1; the disease is Behcet disease.